Signal active
Bio
Allison Baum is a Managing Partner of Fresco Capital and is involved in all aspects of investment and operations with a specific focus on the education technology sector. Previously, as Regional Director of Asia at General Assembly, she established and grew the company’s first education programs for technology, business and design in Hong Kong. She originally joined the company during its early stages in New York where she developed and scaled their first long-form part-time and immersive courses. Throughout this process, Allison has worked with startups of all sizes across New York, San Francisco, Hong Kong, and Tokyo.
After earning a B.A. in Economics and a Secondary Degree in Film Studies from Harvard University, Allison worked in Equity Derivatives Sales & Trading at Goldman Sachs in New York and as an Associate Producer for the Microlending Film Project, a documentary about micro finance for women around the world. She continues to contribute to the cause for female empowerment through an education initiative called Arts and Enterprise for Women, which teaches business skills to refugee and asylum seekers in Hong Kong. She is also an active member of the World Economic Forum’s Global Shapers Community.
Location
N/A
Social
Primary Organization
2018
48
9
1
1-10
Financial Services, Finance, FinTech, Financial Exchanges
Jobs history
1
SemperVirens Venture Capital
General Partner
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Allison Baum Gates is the General Partner at SemperVirens Venture Capital. With a background in Financial Services, Allison Baum Gates has a rich history of leadership and innovation. Allison Baum Gates studied B.A. Economics @ Harvard College. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
6
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Oct 27, 2022 | Midi Health | Seed Round - Midi Health | SemperVirens Venture Capital | 14.0M |
Sep 27, 2023 | Midi Health | Series A - Midi Health | SemperVirens Venture Capital | 25.0M |
Apr 16, 2024 | Take2 AI | Seed Round - Take2 AI | SemperVirens Venture Capital | 3.0M |
Apr 24, 2024 | Midi Health | Series B - Midi Health | SemperVirens Venture Capital | 60.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.